Beneficiaries include mass-market discount stores; chains and independents are suffering
There’s little surprise in the fact that U.S. consumers are more comfortable with generic medications, since the healthcare establishment has been promoting them aggressively for years. Harris Interactive (Rochester, NY) ran a survey on this topic in 2006, and has just repeated it for 2008. Now, the growing acceptance of consumers (from 68% to 81% who express a “preference” for generics) also seems to be affecting the choice of retail pharmacy: When asked, “Where do you go most often to buy prescription drugs?” respondents ranking of discount stores rose (13 to 17%), as did mail order (11% to 15%) and supermarkets (10 to 12%), while chains dropped (39 to 33%) as did independents (12 to 8%).
However, another polling question muddles this trend. When asked specifically about taking advantage of the Wal-Mart or Target pharmacy programs ($4 for a 30-d supply of certain generics; Kmart and other discounters have similar programs, as do some chains) the picture changes. The percentage of “very likely” or “likely” to use the programs dropped from 50% in 2006 to 47% in 2008. The data might be indicative of a difference between those with insurance programs and those without; even though the percentage expressing a preference for discount-store programs dropped, the number who were “absolutely certain” that they would use the programs rose, from 13 to 16%.
Nevertheless, it is striking how much the public’s perception of generics’ value has changed. Only 4% of respondents (down from 9% in 2006) said that they would “always” buy brand-name prescription drugs over generics—which almost suggests that consumers are actively avoiding branded products when given a choice.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.